Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: A gynecologic oncology group study

Frederick B. Stehman, Johannes Blom, John A. Blessing, Clarence E. Ehrlich, Charles Mangan

Research output: Contribution to journalArticle

8 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: A gynecologic oncology group study'. Together they form a unique fingerprint.

Medicine & Life Sciences